HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wartner Acquisition, New Murine Product Steady Prestige Brands’ Q1 Sales

This article was originally published in The Tan Sheet

Executive Summary

Advance sales to retailers of Prestige Brands' new Earigate earwax remover drove a 6 percent increase in sales of products in its Murine line and helped boost the performance of its OTC segment in its latest quarter, company executives said Aug. 8

You may also be interested in...



OraSure Sues To Freeze Prestige’s Purchase Of Wartner Wart Medicines

OraSure Technologies is alleging breach of contract against Prestige Brands following the distributor's $31 mil. acquisition of the Wartner cryosurgical wart removal product line Sept. 25

FTC Views Testimonials As Efficacy Claims, Senior Attorney Warns

The Federal Trade Commission's senior staff attorney for advertising practices recommends firms stay away from using consumer testimonials to assert the benefits of their products

FTC Views Testimonials As Efficacy Claims, Senior Attorney Warns

The Federal Trade Commission's senior staff attorney for advertising practices recommends firms stay away from using consumer testimonials to assert the benefits of their products

Topics

UsernamePublicRestriction

Register

RS138769

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel